Delivery Order SPE2DB24D1104-SPE2DB25FYBF4
- Not listed
- The Defense Logistics Agency awarded a $18,783.85 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for Orencia Clickject 125 mg/mL, a pharmaceutical product for federal medical procurement. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of July 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,594.04 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which involved no set-aside designation, represents a competitively awarded delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a delivery order valued at $82,792.98 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product for federal medical supply needs. The contract, awarded June 2, 2025, with an ultimate completion date of June 3, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $39,227.97 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product for military healthcare needs. This firm fixed-price delivery order, awarded on May 16, 2025, with an ultimate completion date of May 19, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $22,728.76 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/ml, a pharmaceutical product used in treating autoimmune conditions. This non-competitive, firm fixed-price delivery order was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,906.67 for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in treating autoimmune conditions. The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, under firm fixed price terms with no set-aside designation. This delivery order represents a competitive award executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $18,019.38 for Orencia Clickject 125 mg/mL, a biopharmaceutical product. This competitive, non-set-aside contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and features firm fixed pricing. The place of performance is located at the awardee's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $7,188.08 to AmerisourceBergen Drug Corp for Orencia Clickject 125 mg/mL, a specialty pharmaceutical product. The award was made on July 24, 2025, with an ultimate completion date of July 25, 2025, under firm fixed pricing with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitive award to a major pharmaceutical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $14,336.86 by the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of July 15, 2025. The order is for Orencia Clickjet 125 mg/mL, a specialty pharmaceutical product, under firm fixed price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at approximately $73,927 by the Defense Logistics Agency (DLA) on August 26, 2025, with completion targeted for August 27, 2025. The delivery order, which carries no set-aside designation, is for Orencia Clickject 125 mg/ml, a specialty pharmaceutical product to be performed at the vendor's corporate office location in Conshohocken,...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYBF4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $63,197.23 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml on May 20, 2025, with an ultimate completion date of May 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The pharmaceutical product will be delivered to the company's location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products and medical supplies through open competition, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The current award supports military healthcare programs' ongoing pharmaceutical needs and reflects AmerisourceBergen's significant role as a prime vendor in DLA's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $63.2k | 5/20/25 |